Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas
Authors:
- Jesse C. PangJPJesse C. Pang
- Yan-Hui LiuYLYan-Hui Liu
- Edith Y. ChongECEdith Y. Chong
- Yue ChengYCYue Cheng
- Wai-Sang PoonWPWai-Sang Poon
- Ho-Keung NgHNHo-Keung Ng
- 1 May 2001
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 94 (5) , 799-805
Abstract
The loss of genetic material from specific chromosome loci is a common feature in the oncogenesis of tumors and is often indicative of the presence of important tumor suppressor genes at these loci. Recent molecular genetic analyses have demonstrated frequent loss of chromosomes 10q, 11, and 16 in medulloblastomas. The aim of this study was to localize the targeted deletion regions on the three aforementioned chromosomes in medulloblastomas. Loss of heterozygosity (LOH) was examined on chromosomes 10q, 11, and 16 in a series of 22 primary and two recurrent medulloblastomas by using polymerase chain reaction-based microsatellite analysis. The DNA extracted from the tumors and corresponding normal blood samples were amplified independently in the presence of radioactively labeled microsatellite primers, resolved by denaturing gel electrophoresis and processed for autoradiography. The DNA obtained from control blood samples that displayed allelic heterozygosity at a given microsatellite locus were considered informative. Loss of heterozygosity was inferred when the allelic signal intensity of the tumor sample was reduced by at least 40%, relative to that of the constitutional control. The LOH analysis demonstrated that deletions of chromosomes 10q, 11p, and 16q are recurrent genetic events in the development of medulloblastomas. Three subchromosomal regions of loss have been identified and are localized to the deleted in malignant brain tumors 1 [DMBT1] gene site on chromosomes 10q25, 11p13-11p15.1, and 16q24.1-24.3. These results indicate that DMBT1 is closely associated with the oncogenesis of medulloblastomas and highlight regions of loss on chromosomes 11p and 16q for further fine mapping and cloning of candidate tumor suppressor genes that are important for the genesis of medulloblastoma.Keywords
This publication has 30 references indexed in Scilit:
- The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instabilityOncogene, 1999
- ThePISSLREGene: Structure, Exon Skipping, and Exclusion as Tumor Suppressor in Breast CancerGenomics, 1999
- DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumoursNature Genetics, 1997
- RETRACTED: The TSG101 Tumor Susceptibility Gene Is Located in Chromosome 11 Band p15 and Is Mutated in Human Breast CancerCell, 1997
- Deletion mapping of chromosome II in carcinoma of the bladderGenes, Chromosomes and Cancer, 1995
- At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancerGenes, Chromosomes and Cancer, 1994
- Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11 p and 17p in medulloblastomasNeuropathology and Applied Neurobiology, 1994
- Cytogenetic analysis of 109 pediatric central nervous system tumorsCancer Genetics and Cytogenetics, 1993
- Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumorsGenomics, 1992
- Isochromosome 17q in primitive neuroectodermal tumors of the central nervous systemGenes, Chromosomes and Cancer, 1989